Prognostic Factors in Actinic Keratoses

Results: LC-OCT imaging revealed a complete response to Tirbanibulin, with a significant reduction in basal proliferation at 15 days post-treatment.Follow-up at 10 weeks showed continued improvement, with no signs of basal proliferation in the treated lesion.Conclusions: Tirbanibulin demonstrated strong efficacy in treating high-risk, proliferative AKs, as indicated by the complete remission in LC-OCT imaging.These findings highlight the potential of Tirbanibulin for treating proliferative AKs and emphasize the utility of LC-OCT for noninvasive monitoring of therapeutic outcomes.